Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia

Carlo Cervellati, Arianna Romani, Davide Seripa, Eleonora Cremonini, Cristina Bosi, Stefania Magon, Angelina Passaro, Carlo M. Bergamini, Alberto Pilotto, Giovanni Zuliani

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

This study aimed to investigate whether Late Onset Alzheimer's Disease (LOAD) and Vascular Dementia (VAD) might be associated with a distinct profile of oxidative stress (OxS) peripheral markers. Serum levels of hydroperoxides, homocysteine, advanced oxidation protein products, uric acid, thiols, and total and residual antioxidant power were assessed in 103 mild cognitive impairment (MCI), 89 LOAD, 54 VAD patients and 48 Controls. Compared with Controls, a similar oxidative unbalance (high hydroperoxides and low residual antioxidant power) was observed in MCI, LOAD and, although less pronounced, VAD. Moreover, individuals with simultaneously high levels of homocysteine and uric acid, both well-known risk factors for cardiovascular disease, had a high probability to be affected by VAD (O.R.:10.50; 95% C.I.: 2.33-47.2), but not LOAD (O.R.: 3.0; 95% C.I.:0.86-10.76) compared with individuals with normal values. Our data suggest that, although they might share a common OxS-related pathogenesis, VAD and LOAD might maintain some distinctive features, with a predominance of "vascular component" in VAD compared with LOAD.

Original languageEnglish
Pages (from-to)156-161
Number of pages6
JournalJournal of the Neurological Sciences
Volume337
Issue number1-2
DOIs
Publication statusPublished - Feb 15 2014

Fingerprint

Vascular Dementia
Homocysteine
Uric Acid
Alzheimer Disease
Hydrogen Peroxide
Oxidative Stress
Advanced Oxidation Protein Products
Antioxidants
Sulfhydryl Compounds
Blood Vessels
Reference Values
Cardiovascular Diseases
Serum

Keywords

  • Dementia
  • Homocysteine
  • Late Onset Alzheimer's Disease
  • Oxidative stress
  • Uric acid
  • Vascular Dementia

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia. / Cervellati, Carlo; Romani, Arianna; Seripa, Davide; Cremonini, Eleonora; Bosi, Cristina; Magon, Stefania; Passaro, Angelina; Bergamini, Carlo M.; Pilotto, Alberto; Zuliani, Giovanni.

In: Journal of the Neurological Sciences, Vol. 337, No. 1-2, 15.02.2014, p. 156-161.

Research output: Contribution to journalArticle

Cervellati, C, Romani, A, Seripa, D, Cremonini, E, Bosi, C, Magon, S, Passaro, A, Bergamini, CM, Pilotto, A & Zuliani, G 2014, 'Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia', Journal of the Neurological Sciences, vol. 337, no. 1-2, pp. 156-161. https://doi.org/10.1016/j.jns.2013.11.041
Cervellati, Carlo ; Romani, Arianna ; Seripa, Davide ; Cremonini, Eleonora ; Bosi, Cristina ; Magon, Stefania ; Passaro, Angelina ; Bergamini, Carlo M. ; Pilotto, Alberto ; Zuliani, Giovanni. / Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia. In: Journal of the Neurological Sciences. 2014 ; Vol. 337, No. 1-2. pp. 156-161.
@article{9dc7d05c76434417a16d4a4f776c4d54,
title = "Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia",
abstract = "This study aimed to investigate whether Late Onset Alzheimer's Disease (LOAD) and Vascular Dementia (VAD) might be associated with a distinct profile of oxidative stress (OxS) peripheral markers. Serum levels of hydroperoxides, homocysteine, advanced oxidation protein products, uric acid, thiols, and total and residual antioxidant power were assessed in 103 mild cognitive impairment (MCI), 89 LOAD, 54 VAD patients and 48 Controls. Compared with Controls, a similar oxidative unbalance (high hydroperoxides and low residual antioxidant power) was observed in MCI, LOAD and, although less pronounced, VAD. Moreover, individuals with simultaneously high levels of homocysteine and uric acid, both well-known risk factors for cardiovascular disease, had a high probability to be affected by VAD (O.R.:10.50; 95{\%} C.I.: 2.33-47.2), but not LOAD (O.R.: 3.0; 95{\%} C.I.:0.86-10.76) compared with individuals with normal values. Our data suggest that, although they might share a common OxS-related pathogenesis, VAD and LOAD might maintain some distinctive features, with a predominance of {"}vascular component{"} in VAD compared with LOAD.",
keywords = "Dementia, Homocysteine, Late Onset Alzheimer's Disease, Oxidative stress, Uric acid, Vascular Dementia",
author = "Carlo Cervellati and Arianna Romani and Davide Seripa and Eleonora Cremonini and Cristina Bosi and Stefania Magon and Angelina Passaro and Bergamini, {Carlo M.} and Alberto Pilotto and Giovanni Zuliani",
year = "2014",
month = "2",
day = "15",
doi = "10.1016/j.jns.2013.11.041",
language = "English",
volume = "337",
pages = "156--161",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia

AU - Cervellati, Carlo

AU - Romani, Arianna

AU - Seripa, Davide

AU - Cremonini, Eleonora

AU - Bosi, Cristina

AU - Magon, Stefania

AU - Passaro, Angelina

AU - Bergamini, Carlo M.

AU - Pilotto, Alberto

AU - Zuliani, Giovanni

PY - 2014/2/15

Y1 - 2014/2/15

N2 - This study aimed to investigate whether Late Onset Alzheimer's Disease (LOAD) and Vascular Dementia (VAD) might be associated with a distinct profile of oxidative stress (OxS) peripheral markers. Serum levels of hydroperoxides, homocysteine, advanced oxidation protein products, uric acid, thiols, and total and residual antioxidant power were assessed in 103 mild cognitive impairment (MCI), 89 LOAD, 54 VAD patients and 48 Controls. Compared with Controls, a similar oxidative unbalance (high hydroperoxides and low residual antioxidant power) was observed in MCI, LOAD and, although less pronounced, VAD. Moreover, individuals with simultaneously high levels of homocysteine and uric acid, both well-known risk factors for cardiovascular disease, had a high probability to be affected by VAD (O.R.:10.50; 95% C.I.: 2.33-47.2), but not LOAD (O.R.: 3.0; 95% C.I.:0.86-10.76) compared with individuals with normal values. Our data suggest that, although they might share a common OxS-related pathogenesis, VAD and LOAD might maintain some distinctive features, with a predominance of "vascular component" in VAD compared with LOAD.

AB - This study aimed to investigate whether Late Onset Alzheimer's Disease (LOAD) and Vascular Dementia (VAD) might be associated with a distinct profile of oxidative stress (OxS) peripheral markers. Serum levels of hydroperoxides, homocysteine, advanced oxidation protein products, uric acid, thiols, and total and residual antioxidant power were assessed in 103 mild cognitive impairment (MCI), 89 LOAD, 54 VAD patients and 48 Controls. Compared with Controls, a similar oxidative unbalance (high hydroperoxides and low residual antioxidant power) was observed in MCI, LOAD and, although less pronounced, VAD. Moreover, individuals with simultaneously high levels of homocysteine and uric acid, both well-known risk factors for cardiovascular disease, had a high probability to be affected by VAD (O.R.:10.50; 95% C.I.: 2.33-47.2), but not LOAD (O.R.: 3.0; 95% C.I.:0.86-10.76) compared with individuals with normal values. Our data suggest that, although they might share a common OxS-related pathogenesis, VAD and LOAD might maintain some distinctive features, with a predominance of "vascular component" in VAD compared with LOAD.

KW - Dementia

KW - Homocysteine

KW - Late Onset Alzheimer's Disease

KW - Oxidative stress

KW - Uric acid

KW - Vascular Dementia

UR - http://www.scopus.com/inward/record.url?scp=84894065103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894065103&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2013.11.041

DO - 10.1016/j.jns.2013.11.041

M3 - Article

VL - 337

SP - 156

EP - 161

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -